معرفی
Oleg Andreev is a Professor in the Department of Physics at the University of Rhode Island (URI), holding an adjunct position in the Department of Radiation Oncology at Rhode Island Hospital/Warren Alpert Brown Medical School. He has served as Chair of the Physics Department at URI from 2012 to 2019. His academic journey includes roles as Associate Professor (2009–2013), Assistant Professor (2007–2009), and Research Assistant Professor (2005–2007). Prior to URI, he held research positions at Yale University, Sopherion Therapeutics, and various institutions in Russia and the U.S., including Baylor University Medical Center and the University of Texas at Austin.
Andreev’s research focuses on **biological physics** (membrane biophysics, molecular motors, fluorescent microscopy) and **medical physics/nanotechnology** (pH-imaging, drug delivery, tumor targeting). His work emphasizes the development of **pHLIP peptides**, which target acidic diseased tissues for imaging and therapy. These peptides enable intracellular delivery of drugs, fluorescent markers, and nanoparticles to tumors, enhancing cancer diagnostics and treatment.
His **awards** include multiple NIH grants, URI Research Excellence Awards, and the Maitland P. Simmons Memorial Research Award. He has pioneered technologies for **fluorescence-guided surgery**, **PET imaging**, and **gold nanoparticle-based therapies**. His lab collaborates extensively, with over 100 peer-reviewed publications and patents on pHLIP-based applications.
Andreev’s **grants** include NIH R01 funding (2016–2020) totaling $2,282,802. His work has led to inventions recognized by URI’s Outstanding Inventor Award in multiple years. He actively engages in translational research, bridging basic physics with clinical applications in oncology and biomedical engineering.
His **labs/teams** focus on **pHLIP peptide engineering**, **tumor microenvironment analysis**, and **nanomedicine development**, with applications in imaging, drug delivery, and hyperthermia therapies.
